Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Letermovir

EU orphan designation number: EU/3/12/999   
Active ingredient: Letermovir
Indication: Treatment of cytomegalovirus disease in patients with impaired cell mediated immunity
Sponsor: Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/06/2012 Centralised Orphan - Designation EMA/OD/008/12 (2012)3843 of 06/06/2012
19/03/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/008/12/T/01 (2013)1715 of 15/03/2013